Turn Therapeutics (TTRX) Research & Development (2024 - 2026)
Turn Therapeutics' (TTRX) quarterly Research & Development came in at $109434.0 in Q1 2026, up 1081.92% year-on-year from $9259.0 in Q1 2025, and up 74.6% quarter-over-quarter from $62678.0 in Q4 2025.
Turn Therapeutics (TTRX) Research & Development (2024 - 2026) Analysis & Trends
Turn Therapeutics' Research & Development history runs 3 years deep, the most recent figure standing at $109434.0 for Q1 2026.
- On a quarterly basis, Research & Development rose 1081.92% year-over-year to $109434.0 in Q1 2026; TTM through Mar 2026 was $340070.0, a N/A change from a year earlier, with the FY2025 full-year figure at $265570.0, up 7.97% from the prior year.
- Research & Development grew to $109434.0 in Q1 2026 per TTRX's latest filing, from $62678.0 in the prior quarter.
- Across five years, Research & Development topped out at $158699.0 in Q3 2025 and bottomed at $9259.0 in Q1 2025.
- The 3-year median for Research & Development is $86056.0 (2025), against an average of $83853.0.
- Across the five-year window, Research & Development advanced 3.53% in 2025 and jumped 1081.92% in 2026, its largest moves.
- Year by year, Research & Development stood at $9766.0 in 2024, then surged by 541.8% to $62678.0 in 2025, then jumped by 74.6% to $109434.0 in 2026.
- Per Business Quant, the three latest TTRX Research & Development figures stand at $109434.0 (Q1 2026), $62678.0 (Q4 2025), and $158699.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -17.94 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 1.46 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 541.22 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 961.60 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 1.54 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 15.66 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | -443.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 343.97 Mn |
| 10 | Turn Therapeutics | 253.20 Mn | 253.20 Mn | - | 109,434.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 109,434.00 |
| Dec 31, 2025 | 62,678.00 |
| Sep 30, 2025 | 158,699.00 |
| Mar 31, 2025 | 9,259.00 |
| Dec 31, 2024 | 9,766.00 |
| Sep 30, 2024 | 153,282.00 |